Back to Search
Start Over
A Neutrophil Activation Biomarker Panel in Prognosis and Monitoring of Patients With Rheumatoid Arthritis
- Source :
- Arthritis Rheumatol
- Publication Year :
- 2019
-
Abstract
- OBJECTIVE Exaggerated neutrophil activation and formation of neutrophil extracellular traps (NETs) are linked to inflammation and autoimmunity, including rheumatoid arthritis (RA). However, whether NETs are present in the circulation of RA patients and contribute to inflammation and disease progression has not been carefully addressed. We undertook this study to assess markers of neutrophil activation and NET formation in plasma samples, investigating whether they add clinical value in improving the determination of prognosis and monitoring in RA patients. METHODS Markers of neutrophil activation (calprotectin) and cell death (NETs) were analyzed, using enzyme-linked immunosorbent assay, in serum and plasma obtained from patients in 3 cross-sectional RA cohorts and sex-matched healthy controls. A longitudinal inception cohort (n = 247), seen for a median follow-up of 8 years, was used for predictive analyses. RESULTS Markers of neutrophil activation and cell death were increased in RA patients compared to healthy individuals (P < 0.0001). Calprotectin levels correlated with the Clinical Disease Activity Index (r = 0.53, P < 0.0001) and could be used to distinguish between patients with disease in remission and those with active disease, an observation not seen when examining C-reactive protein levels. A biomarker panel consisting of anti-citrullinated protein antibody and calprotectin could predict erosive disease (odds ratio [OR] 7.5, P < 0.0001) and joint space narrowing (OR 4.9, P = 0.001). NET levels were associated with markers of inflammation (P = 0.0002). Furthermore, NETs and a "neutrophil activation signature" biomarker panel had good predictive value in identifying patients who were developing extraarticular nodules (OR 5.6, P = 0.006). CONCLUSION Neutrophils undergo marked activation and cell death in RA. Neutrophil biomarkers can provide added clinical value in the monitoring and prognosis of RA patients and may allow for early preventive treatment intervention.
- Subjects :
- 0301 basic medicine
Adult
Male
medicine.medical_specialty
Adolescent
Immunology
Arthritis
Inflammation
medicine.disease_cause
Gastroenterology
Extracellular Traps
Anti-Citrullinated Protein Antibodies
Neutrophil Activation
Article
Autoimmunity
Arthritis, Rheumatoid
03 medical and health sciences
Young Adult
0302 clinical medicine
Rheumatology
Internal medicine
medicine
Immunology and Allergy
Humans
Longitudinal Studies
Aged
030203 arthritis & rheumatology
Cell Death
business.industry
Interleukin-6
Case-control study
Odds ratio
Neutrophil extracellular traps
Middle Aged
medicine.disease
Prognosis
030104 developmental biology
C-Reactive Protein
Rheumatoid arthritis
Case-Control Studies
Female
medicine.symptom
Calprotectin
business
Leukocyte L1 Antigen Complex
Biomarkers
Subjects
Details
- ISSN :
- 23265205
- Volume :
- 72
- Issue :
- 1
- Database :
- OpenAIRE
- Journal :
- Arthritisrheumatology (Hoboken, N.J.)
- Accession number :
- edsair.doi.dedup.....3cd9fd55a2b8001b463bbea665aec133